HIV Seropositivity

• 

  Subject Areas on Research

  • A Qualitative Exploration of the Mental Health and Psychosocial Contexts of HIV-Positive Adolescents in Tanzania. 
  • A comparison of HIV-positive patients with and without infective endocarditis: an echocardiographic study--the Emory Endocarditis Group experience. 
  • A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa. 
  • A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. 
  • A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera. 
  • A qualitative analysis of partner selection, HIV serostatus disclosure, and sexual behaviors among HIV-positive urban men. 
  • AIDS cholangiopathy as the first sign of HIV infection. 
  • AIDS/HIV. Host controls of HIV neutralizing antibodies. 
  • Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. 
  • Accumulated mutations by 6 months of infection collectively render transmitted/founder HIV-1 significantly less fit. 
  • Acquired immunodeficiency syndrome-like illness associated with systemic Mycoplasma fermentans infection in a human immunodeficiency virus-negative homosexual man. 
  • Addressing Polypharmacy in Older Adults Living With HIV. 
  • Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? 
  • Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. 
  • Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. 
  • Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk. 
  • Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. 
  • Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. 
  • Application of lipoarabinomannan antigen in tuberculosis diagnostics: current evidence. 
  • Assessing psychological symptom networks related to HIV-positive duration among people living with HIV: a network analysis. 
  • Avoidant Coping Mediates the Relationship Between Self-Efficacy for HIV Disclosure and Depression Symptoms Among Men Who Have Sex with Men Newly Diagnosed with HIV. 
  • Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens. 
  • Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records. 
  • Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models. 
  • Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01. 
  • CD3+CD8+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: a report from the heterosexual HIV transmission study. 
  • CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. 
  • Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals. 
  • Cellular immune response to viral peptides in patients exposed to HIV. 
  • Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods. 
  • Changes in HIV risk behavior and seroincidence among clients presenting for repeat HIV counseling and testing in Moshi, Tanzania. 
  • Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. 
  • Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. 
  • Characteristics of high-risk HIV-positive IDUs in Vietnam: implications for future interventions. 
  • Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life. 
  • Community-based voluntary counseling and testing services in rural communities of Chiang Mai Province, Northern Thailand. 
  • Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer. 
  • Complex transmission dynamics of clonally related virulent Mycobacterium tuberculosis associated with barhopping by predominantly human immunodeficiency virus-positive gay men. 
  • Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models. 
  • Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. 
  • Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states. 
  • Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges. 
  • Correlates of Self-Reported Viral Suppression Among HIV-Positive, Young, Black Men Who Have Sex With Men Participating in a Randomized Controlled Trial of An Internet-Based HIV Prevention Intervention. 
  • Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. 
  • Cytomegalovirus retinitis in HIV-infected patients with elevated CD4+ counts. 
  • Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection. 
  • Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network. 
  • Detection of Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient. 
  • Development of Antibodies with Broad Neutralization Specificities against HIV-1 after Long Term SHIV Infection in Macaques. 
  • Development of Neutralization Breadth against Diverse HIV-1 by Increasing Ab-Ag Interface on V2. 
  • Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay. 
  • Diversity of full-length subtype E HIV type 1 env sequences in early seroconvertors from northern Thailand. 
  • Donor evaluation in the era of HIV-positive organ transplantation: The importance of the infectious diseases specialist. 
  • Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study. 
  • Early detection: the next steps. 
  • Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study. 
  • Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. 
  • Epidemiology of HIV-1 infection in opiate users in Northern Thailand. 
  • Estimating the cost of unmet HIV-prevention needs in the United States. 
  • Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. 
  • Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. 
  • Evolving symptom networks in relation to HIV-positive duration among people living with HIV: A network analysis. 
  • Examining the role of serostatus disclosure on unprotected sex among people living with HIV. 
  • Exploring lack of trust in care providers and the government as a barrier to health service use. 
  • Factors associated with failure to list HIV-positive kidney transplant candidates. 
  • Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. 
  • Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial. 
  • Feasibility of northern Thai factory workers as participants in HIV vaccine trials. 
  • Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon. 
  • GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody. 
  • Gender differences in the risk of HIV infection among persons reporting abstinence, monogamy, and multiple sexual partners in northern Tanzania. 
  • Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa. 
  • Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. 
  • Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions. 
  • Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings. 
  • Guidelines for effective integration of information technology in the care of HIV-infected populations. 
  • HIV incidence and mortality in transgender women in the eastern and southern USA: a multisite cohort study. 
  • HIV infection among female drug users in Northern Thailand. 
  • HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. 
  • HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. 
  • HIV risks among injecting and non-injecting female partners of men who inject drugs in Almaty, Kazakhstan: implications for HIV prevention, research, and policy. 
  • HIV testing and sero-prevalence among methamphetamine users seeking substance abuse treatment in Cape Town. 
  • HIV testing of at risk patients in a large integrated health care system. 
  • HIV therapeutics: an emerging science. 
  • HIV-1 Vpu restricts Fc-mediated effector functions in vivo. 
  • HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. 
  • HIV-1 reservoir evolution in infants infected with clade C from Mozambique. 
  • HIV-1 sensitivity to zidovudine and clinical outcome. 
  • HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities. 
  • HIV-1-associated thrombocytopenia. The role of splenectomy. 
  • HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection. 
  • HIV-associated morbidity, mortality and diagnostic testing opportunities among inpatients at a referral hospital in northern Tanzania. 
  • HIV/AIDS-related institutional mistrust among multiethnic men who have sex with men: effects on HIV testing and risk behaviors. 
  • HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers. 
  • HPTN 062: a feasibility and acceptability pilot intervention to reduce HIV transmission risk behaviors among individuals with acute and early HIV infection in Lilongwe, Malawi. 
  • Health department collaboration with emergency departments as a model for public health programs among at-risk populations. 
  • Heart Transplantation Survival Outcomes of HIV Positive and Negative Recipients. 
  • Hematogenous patellar osteomyelitis associated with human immunodeficiency virus. 
  • Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. 
  • Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study. 
  • Herpesvirus saimiri transformation of HIV type 1 suppressive CD8+ lymphocytes from an HIV type 1-infected asymptomatic individual. 
  • High versus low basal cortisol secretion in asymptomatic, medication-free HIV-infected men: differential effects of severe life stress on parameters of immune status. 
  • High-resolution computed tomography in the diagnosis of miliary tuberculosis. 
  • Hip arthroplasty in hemophilic arthropathy. 
  • Histoplasmosis among hospitalized febrile patients in northern Tanzania. 
  • Host Cell Redox Alterations Promote Latent HIV-1 Reactivation through Atypical Transcription Factor Cooperativity. 
  • Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen. 
  • Human immunodeficiency virus-1 disease progression in hemophiliacs. 
  • Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. 
  • Idiopathic CD4+ T-lymphocytopenia. 
  • Immune correlates of HIV-1 reservoir cell decline in early-treated infants. 
  • Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression. 
  • Improvements in health-related quality of life following a group intervention for coping with AIDS-bereavement among HIV-infected men and women. 
  • Improving participant understanding of informed consent in an HIV-prevention clinical trial: a comparison of methods. 
  • In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. 
  • In-home mental health treatment for individuals with HIV. 
  • Incident sexually transmitted infection as a biomarker for high-risk sexual behavior after diagnosis of acute HIV. 
  • Incident stressful and traumatic life events and human immunodeficiency virus sexual transmission risk behaviors in a longitudinal, multisite cohort study. 
  • Individual and partner characteristics associated with HIV testing and counseling uptake among individuals 50 years or older in Tanzania. 
  • Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques. 
  • Infant birth weight among women with or at high risk for HIV infection: the impact of clinical, behavioral, psychosocial, and demographic factors. 
  • Infected joint replacements in HIV-positive patients with haemophilia. 
  • Influence of HIV-1 infection and cigarette smoking on leukocyte profile in homosexual men. 
  • Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1. 
  • Insomnia in HIV-infected patients: pathophysiologic implications. 
  • Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. 
  • Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1. 
  • Lifetime correlates associated with amphetamine use among northern Thai men attending STD and HIV anonymous test sites. 
  • Loop electrosurgical excision procedure: safety and tolerability among human immunodeficiency virus-positive Kenyan women. 
  • Loss to follow-up effect in investigations of HIV-1 incidence. 
  • Low HIV seroincidence among female commercial sex workers: a barrier for measuring HIV vaccine efficacy. 
  • Low rates of child testing for HIV persist in a high-risk area of East Africa. 
  • Lymphocyte immunoregulatory cells present in semen from human immunodeficiency virus (HIV)-infected individuals: a report from the HIV Heterosexual Transmission Study. 
  • Lymphocyte shedding from genital tract of human immunodeficiency virus-infected women: immunophenotypic and clinical correlates. 
  • Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs. 
  • Missed opportunities for diagnosis of tuberculosis and human immunodeficiency virus co-infection in Moshi, Tanzania. 
  • Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. 
  • Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines. 
  • NIMH Project Accept (HPTN 043) HIV/AIDS community mobilization (CM) to promote mobile HIV voluntary counseling and testing (MVCT) in rural communities in Northern Thailand: modifications by experience. 
  • National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States. 
  • Neurobehavioral functioning in a nonconfounded group of asymptomatic HIV-seropositive homosexual men. 
  • Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. 
  • New Hampshire: the premarital testing debacle. 
  • Nosocomial infection rate as a function of human immunodeficiency virus type 1 status in hemophiliacs. 
  • Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes. 
  • Orphan status, HIV risk behavior, and mental health among adolescents in rural Kenya. 
  • Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection. 
  • Perceived acceptability of home-based couples voluntary HIV counseling and testing in Northern Tanzania. 
  • Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. 
  • Physiological correlates of HIV-related fatigue. 
  • Potential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection. 
  • Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants. 
  • Predictors of relapse in sexual practices among homosexual men. 
  • Preexposure prophylaxis for HIV infection among African women. 
  • Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors. 
  • Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. 
  • Prevalence and correlates of intimate partner violence among women attending HIV voluntary counseling and testing in northern Tanzania, 2005-2008. 
  • Prevalence estimation and validation of new instruments in psychiatric research: an application of latent class analysis and sensitivity analysis. 
  • Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy. 
  • Rapid freezing of whole blood or buffy coat samples for polymerase chain reaction and cell culture analysis: application to detection of human immunodeficiency virus in blood donor and recipient repositories. The Transfusion Safety Study Group. 
  • Rational testing of the HIV-exposed infant. 
  • Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: a comparison of three models. 
  • Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. 
  • Rhodococcus equi causing human pulmonary infection: review of 29 cases. 
  • Risk of infection of health-care workers by human immunodeficiency virus. 
  • Rosai-Dorfman disease (extranodal sinus histiocytosis) in a patient with HIV. 
  • Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young Children. 
  • Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals. 
  • Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial. 
  • Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study. 
  • Scientific and social issues of human immunodeficiency virus vaccine development. 
  • Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland. 
  • Seizure associated with zidovudine. 
  • Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants. 
  • Serostatus disclosure to sexual partners among people living with HIV: examining the roles of partner characteristics and stigma. 
  • Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy. 
  • Service delivery characteristics associated with contraceptive use among youth clients in integrated voluntary counseling and HIV testing clinics in Kenya. 
  • Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: associations of risk with genetic complexity. 
  • Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage. 
  • Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates. 
  • Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I. 
  • Stress and coping in HIV-positive former plasma/blood donors in China: a test of cognitive appraisal theory. 
  • Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies. 
  • Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. 
  • Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth. 
  • Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group. 
  • Systematic review of the performance of HIV viral load technologies on plasma samples. 
  • The Cognitive Escape Scale: measuring HIV-related thought avoidance. 
  • The association between substance use and sub-optimal HIV treatment engagement among HIV-infected female sex workers in Lilongwe, Malawi. 
  • The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study. 
  • The gelatinous bone marrow (serous atrophy) in patients with acquired immunodeficiency syndrome. Evidence of excess sulfated glycosaminoglycan. 
  • The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat. 
  • The introduction of human immunodeficiency virus into the North Carolina pediatric population. 
  • The natural history of HIV-1 infection in young Thai men after seroconversion. 
  • The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine. 
  • The right to privacy and the duty to protect. 
  • The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models. 
  • The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. 
  • The varied manifestations of disseminated gonococcal infection. 
  • Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. 
  • Time trends in management of HIV-positive pregnant women in Northern Tanzania: A registry-based study. 
  • Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. 
  • Timing of HIV Seroreversion Among HIV-Exposed, Breastfed Infants in Malawi: Type of HIV Rapid Test Matters. 
  • Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. 
  • Transmission of human immunodeficiency virus to sexual partners of hemophiliacs. 
  • Transplantation in the HIV+ patient. 
  • Trauma, anxiety and reported health among HIV-positive persons in Tanzania and the US Deep South. 
  • Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. 
  • Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians. 
  • Treatment Failures and Excess Mortality Among HIV-Exposed, Uninfected Children With Pneumonia. 
  • Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). 
  • Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina. 
  • Uncovering the epidemic of HIV among men who have sex with men in Central Asia. 
  • Understanding the Effects of Multiple Stigmas Among Formerly Incarcerated HIV-Positive African American Men. 
  • Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. 
  • Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses. 
  • Violence, homelessness, and HIV risk among crack-using African-American women. 
  • WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study. 
  • fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence. 
• 

  Keywords of People

  • Weinhold, Kent James, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Integrative Immunobiology